Wells Fargo
AFIB

Wells Fargo’s Acutus Medical Inc AFIB Stock Holding History

Wells Fargo’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,238
Closed -$1.17K – 7702
2024
Q1 		$1.17K Buy
6,238
+3
+0% +$1 ﹤0.01% 6117
2023
Q4 		$1.26K Buy
6,235
+10
+0.2% +$4 ﹤0.01% 6178
2023
Q3 		$4.34K Buy
6,225
+1,381
+29% +$895 ﹤0.01% 5974
2023
Q2 		$4.3K Buy
4,844
+8
+0.2% +$7 ﹤0.01% 6097
2023
Q1 		$3.65K Buy
4,836
+2
+0% +$3 ﹤0.01% 6123
2022
Q4 		$5.56K Sell
4,834
-196
-4% -$162 ﹤0.01% 5737
2022
Q3 		$4K Buy
5,030
+12
+0.2% +$15 ﹤0.01% 6006
2022
Q2 		$5K Sell
5,018
-4,182
-45% -$3.59K ﹤0.01% 6040
2022
Q1 		$13K Sell
9,200
-6,666
-42% -$14.3K ﹤0.01% 6186
2021
Q4 		$54K Buy
15,866
+11,213
+241% +$63.2K ﹤0.01% 5941
2021
Q3 		$41K Buy
4,653
+1,153
+33% +$15.2K ﹤0.01% 5706
2021
Q2 		$59K Sell
3,500
-75,161
-96% -$1.1M ﹤0.01% 5498
2021
Q1 		$1.05M Sell
78,661
-301,061
-79% -$6.78M ﹤0.01% 4210
2020
Q4 		$10.9M Buy
379,722
+9,586
+3% +$259K ﹤0.01% 2012
2020
Q3 		$11M Buy
+370,136
New +$11.2M ﹤0.01% 1827

Other funds holding AFIB

SAM
S.A. Mason Holland, Michigan $266M AUM 26.42% 1-Year Est. Return

Wells Fargo's AFIB Position: Q2 2024 in Review

Wells Fargo sold out of Acutus Medical Inc (AFIB) in Q2 2024, closing a stake of 6,238 shares — an estimated $1.17K sold.

Wells Fargo first reported a position in AFIB in Q3 2020 and held it in 15 quarters. The position peaked at $11M in Q3 2020. 1 fund tracked by Wall St. Rank holds AFIB as of Q2 2024.

  • Wells Fargo reported no remaining Acutus Medical Inc position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 6,238 Acutus Medical Inc shares in Q2 2024, an estimated $1.17K.
  • Wells Fargo first reported a position in Acutus Medical Inc in Q3 2020 and held it in 15 quarters.
  • Wells Fargo's Acutus Medical Inc position peaked at $11M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.